España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
AN2 Therapeutics
ANTX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.26
-0.01
-0.79%
At close: -
$1.26
0.00
0.00%
After Hours: Dec 20, 4:00 PM EDT
Get Report
Comment
AN2 Therapeutics (ANTX) Forecast
News
Earnings
AN2 Therapeutics (ANTX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for AN2 Therapeutics (NASDAQ:ANTX) Stock
AN2 Therapeutics Stock (NASDAQ: ANTX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, November 19, 2024
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Monday, November 18, 2024
TD Cowen Downgrades AN2 Therapeutics to Hold
Benzinga Newsdesk
Wednesday, November 13, 2024
AN2 Therapeutics Provides Important EBO-301 U...
Benzinga Newsdesk
AN2 Therapeutics Q3 EPS $(0.43) Beats $(0.54)...
Benzinga Newsdesk
Thursday, October 17, 2024
AN2 Therapeutics Receives Continuation Grant ...
Benzinga Newsdesk
Thursday, October 03, 2024
Why Levi Strauss Shares Are Trading Lower By Over 10%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Monday, August 19, 2024
AN2 Therapeutics Plunges 66% in a Month: Here's Why
Zacks
Friday, August 16, 2024
AN2 Therapeutics Adopts Limited Duration Stoc...
Benzinga Newsdesk
Thursday, August 15, 2024
Citizens And 2 Other Penny Stocks Insiders Are Buying
Avi Kapoor
Tuesday, August 13, 2024
AN2 Therapeutics Q2 EPS $(0.48) Beats $(0.59)...
Benzinga Newsdesk
Friday, August 09, 2024
Crude Oil Rises; Blend Labs Shares Jump Following Q2 Results
Avi Kapoor
US Stocks Edge Lower; EchoStar Shares Tumble After Q2 Results
Avi Kapoor
Lung Disease Focused AN2 Therapeutics' Lackluster Data Prompts To Stop Phase 3 Study Of Lung Infection Candidate, Halves Workforce
Vandana Singh
AN2 Therapeutics shares are trading lower aft...
Benzinga Newsdesk
JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk
Thursday, August 08, 2024
AN2 Therapeutics shares are trading lower aft...
Benzinga Newsdesk
AN2 Therapeutics Announces Update On EBO-301 ...
Benzinga Newsdesk
Wednesday, July 03, 2024
Leerink Partners Upgrades AN2 Therapeutics to...
Benzinga Newsdesk
Friday, June 14, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Thursday, May 16, 2024
Evercore ISI Group Maintains In-Line on AN2 T...
Benzinga Newsdesk
Thursday, April 04, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Tuesday, April 02, 2024
JMP Securities Upgrades AN2 Therapeutics to M...
Benzinga Newsdesk
Monday, April 01, 2024
Oppenheimer Reiterates Perform on AN2 Therape...
Benzinga Newsdesk
Thursday, March 28, 2024
AN2 Therapeutics Q4 EPS $(0.57) Beats $(0.76)...
Benzinga Newsdesk
Tuesday, February 13, 2024
ZoomInfo Technologies To Rally Around 50%? Here Are 10 Top Analyst Forecasts For Tuesday
Avi Kapoor
Leerink Partners Downgrades AN2 Therapeutics ...
Benzinga Newsdesk
Monday, February 12, 2024
Nasdaq Edges Lower; ContextLogic Shares Surge
Avi Kapoor
Why Big Lots Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
Evercore ISI Group Downgrades AN2 Therapeutic...
Benzinga Newsdesk
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Dow Surges Over 150 Points; Gilead Sciences To Acquire CymaBay Therapeutics For $4.3B
Avi Kapoor
Oppenheimer Downgrades AN2 Therapeutics to Pe...
Benzinga Newsdesk
JMP Securities Downgrades AN2 Therapeutics to...
Benzinga Newsdesk
US Stocks Mixed; Trimble Issues Weak Outlook
Avi Kapoor
Why Is Infectious Disease-Focused AN2 Therapeutics Stock Sinking Today?
Vandana Singh
AN2 Therapeutics shares are trading lower aft...
Benzinga Newsdesk
Monday.com Reports Q4 Results, Joins AN2 TherapeuticsAnd Other Big Stocks Moving Lower In Monday's Pre-Market Session
Avi Kapoor
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
AN2 Therapeutics to Voluntarily Pause Enrollm...
Benzinga Newsdesk
Thursday, January 04, 2024
JMP Securities Initiates Coverage On AN2 Ther...
Benzinga Newsdesk
Thursday, November 09, 2023
AN2 Therapeutics Q3 EPS $(0.65) Beats $(0.70)...
Benzinga Newsdesk
Wednesday, October 18, 2023
AN2 Therapeutics Signs License Agreement With...
Benzinga Newsdesk
Wednesday, October 11, 2023
AN2 Therapeutics To Present New Data for Epet...
Benzinga Newsdesk
Tuesday, September 26, 2023
AN2 Therapeutics Signs Grant Agreement To Dis...
Benzinga Newsdesk
Wednesday, September 13, 2023
AN2 Therapeutics Has Commenced The Phase 3 Pa...
Benzinga Newsdesk
Wednesday, September 06, 2023
Top 5 Health Care Stocks That May Fall Off A Cliff
Lisa Levin
Wednesday, August 23, 2023
AN2 Therapeutics 10% Owner Makes $16.00M Stock Purchase
Benzinga Insights
$16M Bet On This Biotechnology Stock? Check Out These 3 Stocks Insiders Are Buying
Lisa Levin
Thursday, August 17, 2023
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Wednesday, August 16, 2023
AN2 Therapeutics Announces Pricing Of $70M Underwritten Offering Of 7,777,778 Shares Of Common Stock At A Price Of $9/Share
Happy Mohamed
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch